Anti-diabetic drugs could lower risk of primary and secondary brain cancer
Diabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University ...
Feb 22, 2024
0
9